Chris Ho

Dr. Ho founded Drug Design Methodologies, which produced and licensed two highly successful commercial packages, RACHEL and CHARLIE, through Tripos, Inc. These products helped chemists refine weak binding leads into much more potent drugs. Over forty major pharmaceutical companies licensed these products until Tripos was sold to private investors in 2009. While at DDM, he maintained a senior scientist position in the Biochemistry Dept. at Washington University where he collaborated with numerous academic departments to develop ligands against specific targets. Dr. Ho has also served as a consultant to many pharmaceutical companies, including Monsanto, Pfizer and DuPont. Dr. Ho is a graduate of Purdue University and completed his MD/PhD from Washington University School of Medicine in St. Louis.